Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.

Background: A quarter of people with Intellectual Disability (ID) in the UK have epilepsy compared to 0.6% in the general population and die much younger. Epilepsy is associated with two-fifths of all deaths with related polypharmacy and multi-morbidity.